1666 Share Price Performance
HK$4.79
-1.10 (-18.68%)
Price HK$4.79
Share PriceHK$4.79
Tong Ren Tang Technologies' (HKG:1666) Soft Earnings Are Actually Better Than They Appear
Sep 02
Tong Ren Tang Technologies Co. Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
1666 Community Narratives
There are no narratives available yet.
Tong Ren Tang Technologies Co. Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.34
- Gross Margin
- 39.82%
- Net Profit Margin
- 6.21%
- Debt/Equity Ratio
- 21.7%
Tong Ren Tang Technologies Co. Ltd. Competitors
Snowflake Analysis
About 1666
- Founded
- 1669
- Employees
- 3888
- CEO
- WebsiteView website
Tong Ren Tang Technologies Co. Ltd., together with its subsidiaries, produces and distributes Chinese medicine products in Mainland China and Hong Kong. It operates through The Company; Tong Ren Tang Chinese Medicine; and Others segments. The company also develops, cultivates, processes, and purchases Chinese medicinal raw materials; retails and wholesales Chinese medicine products and healthcare products; and offers ointments, healthcare products, tea drinks, food, foot care products, biological products, western medicine, and cosmetics. In addition, it provides medical research and development; advertisement; and Chinese medical consultations and treatments. Further, the company produces and processes biochemical products; extracts and processes plants; and offers medical services. Tong Ren Tang Technologies Co. Ltd. was founded in 1669 and is based in Beijing, the People’s Republic of China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0%
- 3 Months: 17.2%
- 1 Year: 15.8%
- Year to Date: 26.2%
The market has stayed flat over the 7 days. As for the longer term, the market has risen 16% in the past 12 months. Looking forward, earnings are forecast to grow by 27% annually. Market details ›